PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 106 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 3.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $380 | -26.9% | 123 | 0.0% | 0.00% | – |
Q4 2022 | $520 | – | 123 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 123 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 123 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 123 | +66.2% | 0.00% | – |
Q4 2019 | $0 | – | 74 | 0.0% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 74 | -99.9% | 0.00% | -100.0% |
Q2 2019 | $1,518,000 | -74.2% | 119,464 | -21.2% | 0.00% | -83.3% |
Q1 2019 | $5,879,000 | – | 151,586 | +2526333.3% | 0.01% | – |
Q1 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 6 | -99.3% | 0.00% | – |
Q2 2017 | $77,000 | +108.1% | 880 | -12.0% | 0.00% | – |
Q1 2017 | $37,000 | +19.4% | 1,000 | 0.0% | 0.00% | – |
Q4 2016 | $31,000 | +416.7% | 1,000 | +900.0% | 0.00% | – |
Q3 2016 | $6,000 | 0.0% | 100 | -50.0% | 0.00% | – |
Q1 2016 | $6,000 | -62.5% | 200 | 0.0% | 0.00% | – |
Q4 2015 | $16,000 | -87.2% | 200 | -88.0% | 0.00% | – |
Q3 2015 | $125,000 | -39.3% | 1,666 | -5.6% | 0.00% | – |
Q2 2015 | $206,000 | +82.3% | 1,764 | +264.5% | 0.00% | – |
Q1 2015 | $113,000 | +79.4% | 484 | +48.0% | 0.00% | – |
Q4 2014 | $63,000 | +103.2% | 327 | +151.5% | 0.00% | – |
Q3 2014 | $31,000 | +520.0% | 130 | +85.7% | 0.00% | – |
Q2 2014 | $5,000 | -66.7% | 70 | -52.1% | 0.00% | – |
Q1 2014 | $15,000 | -81.2% | 146 | -92.0% | 0.00% | – |
Q2 2013 | $80,000 | – | 1,820 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 207,500 | $21,609,000 | 4.97% |
WEATHERBIE CAPITAL, LLC | 250,296 | $26,066,000 | 2.47% |
Redmile Group, LLC | 172,092 | $17,922,000 | 2.14% |
Tekla Capital Management LLC | 185,820 | $19,351,000 | 1.93% |
Iguana Healthcare Management, LLC | 35,000 | $3,645,000 | 1.68% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $592,210,000 | 1.62% |
Atika Capital Management LLC | 11,350 | $1,182,000 | 1.01% |
Eventide Asset Management | 44,900 | $4,676,000 | 0.73% |
Ghost Tree Capital, LLC | 11,330 | $1,180,000 | 0.70% |
BB BIOTECH AG | 117,991 | $12,288,000 | 0.63% |